511
Downloads
13
Episodes
The Life Sciences D’n’A podcast is hosted by Dr. Amar Drawid, an industry veteran and AI expert who has worked in data science leadership with top biopharmaceutical companies. He explores the evolving use of AI and data science with innovators working to reshape all aspects of the biopharmaceutical industry from the way new therapeutics are discovered to how they are marketed.
Episodes
Thursday Sep 12, 2024
Tackling the New Bottleneck of Drug Discovery
Thursday Sep 12, 2024
Thursday Sep 12, 2024
Markus Gershater, chief scientific officer and co-founder of Synthace sits down with Amar Drawid to discuss Synthace’s AI-based platform that enables drug developers to design complex experiments, run them, and capture and analyze the data all in an automated way.
Thursday Aug 22, 2024
Swimming in the Deep End of AI
Thursday Aug 22, 2024
Thursday Aug 22, 2024
Brendan Frey, founder and chief innovation officer of Deep Genomics, sits down with Amar Drawid to discuss how the company is using deep learning to leverage massive RNA biology datasets to drive the development of new therapies.
Thursday Jul 25, 2024
Using AI to Make Biology Easier to Engineer
Thursday Jul 25, 2024
Thursday Jul 25, 2024
Ankit Gupta, the head of AI and Senior Director of Machine Learning Research for Ginkgo Bioworks sits down with Amar Drawid to discuss bioengineering beyond healthcare, how the company is using generative AI and large language models to accelerate bioengineering, it expects this to revolutionize the field.
Thursday Jun 27, 2024
How AI ls Reshaping the Future of Healthcare
Thursday Jun 27, 2024
Thursday Jun 27, 2024
Subodha Kumar, professor of statistics, operations, and data science and the founding director of the Center for Business Analytics and Disruptive Technologies at Temple University’s Fox School of Business, sits down with Amar Drawid to discuss how AI will improve operational efficiency in healthcare, enable mass customization for patients, and free providers up to focus on high-value decision making.
Thursday Jun 13, 2024
A Venture Studio with Big Pharma Backing Seeks to Fix Drug Development with AI
Thursday Jun 13, 2024
Thursday Jun 13, 2024
Mati Gill, CEO of AION Labs, sits down with Amar Drawid to discuss how the AI venture studio works with its Big Pharma partners to define the biggest drug development hurdles the industry faces; and how it holds challenges to attract academics, entrepreneurs, and life sciences professionals with the best solutions to build new companies.
Thursday May 30, 2024
Decoding the Immune System to Optimize Immunotherapies
Thursday May 30, 2024
Thursday May 30, 2024
Noam Solomon, co-founder and CEO of Immunai, sits down with Amar Drawid to discuss how the company is using machine learning to take a multi-omics approach to understanding the complexities of the immune system, how it is constructing an atlas of immune cells, and how it is leveraging this to develop the next generation of immunomodulatory drugs.
Thursday May 09, 2024
Bringing Precision Medicine to Mental Health with AI
Thursday May 09, 2024
Thursday May 09, 2024
Behavioral health is one area of medicine that has lagged in the move towards precision medicine, in part because of a lack of high-quality evidence to drive decision-making. Holmusk is working to change that by using AI and real-world data to transform mental health care. Eze Abosi, chief growth officer for Holmusk, sits down with Amar Drawid to discuss the need for standardized ways to measure symptoms for behavioral health conditions. They talk about how Holmusk is unlocking much-needed evidence to guide the successful development of new therapies, how its platform technology works, and why he believes it is charting a path for bringing precision medicines to people with mental health conditions.
Thursday Apr 25, 2024
The Power and Peril of Generative AI in Biopharma and Healthcare
Thursday Apr 25, 2024
Thursday Apr 25, 2024
Healthtech and AI Executive Advisor Christian Hein sits down with Amar Drawid to discuss the use of generative AI in the life sciences, its transformational potential, and the current challenges that need to be addressed.
Dr. Amar Drawid
Dr. Amar Drawid is the host of Life Science D’n’A podcast and currently serves as chief AI and business consulting officer for Agilisium Consulting. For nearly 25 years, he has worked in bioinformatics, data analytics, and AI within the life sciences industry with such companies as Sanofi, Celgene, and Novartis. He holds an M.S. and B.S. in bioinformatics, computer science, and molecular biophysics and biochemistry from Yale University and a Ph.D. in computational biology and molecular biophysics (artificial intelligence/machine learning) from Rutgers University